Cargando…
Therapeutic effect of melatonin-loaded chitosan/lecithin nanoparticles on hyperglycemia and pancreatic beta cells regeneration in streptozotocin-induced diabetic rats
Nanotechnology is used to overcome fundamental flaws in today's marketed pharmaceuticals that obstruct therapy, like restricted solubility and quick release of drugs into the bloodstream. In both human and animal researches, melatonin was demonstrated to regulate glucose levels. Despite the fac...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10313733/ https://www.ncbi.nlm.nih.gov/pubmed/37391460 http://dx.doi.org/10.1038/s41598-023-36929-0 |
_version_ | 1785067179091165184 |
---|---|
author | Alaa, Habiba Abdelaziz, Mariam Mustafa, Maryam Mansour, Mustafa Magdy, Salma Mohsen, Salma El-Karamany, Yomna Farid, Alyaa |
author_facet | Alaa, Habiba Abdelaziz, Mariam Mustafa, Maryam Mansour, Mustafa Magdy, Salma Mohsen, Salma El-Karamany, Yomna Farid, Alyaa |
author_sort | Alaa, Habiba |
collection | PubMed |
description | Nanotechnology is used to overcome fundamental flaws in today's marketed pharmaceuticals that obstruct therapy, like restricted solubility and quick release of drugs into the bloodstream. In both human and animal researches, melatonin was demonstrated to regulate glucose levels. Despite the fact that melatonin is quickly transported through the mucosa, its sensitivity to be oxidized creates a difficulty in achieving the required dose. Additionally, due to its variable absorption and poor oral bioavailability necessitates the development of alternative delivery methods. The study aimed to synthesize melatonin loaded chitosan/lecithin (Mel-C/L) nanoparticles to be assessed in the treatment of streptozotocin (STZ)-induced diabetes in rats. The antioxidant, anti-inflammatory, and cytotoxicity properties of nanoparticles were estimated to determine the safety of manufactured nanoparticles for in vivo studies. In addition, Mel-C/L nanoparticles were administered to rats for eight weeks after inducing hyperglycemia. The therapeutic effect of Mel-C/L nanoparticles was assessed in all experimental groups by detecting insulin and blood glucose levels; observing improvements in liver and kidney functions as well as histological and immunohistochemical evaluation of rats’ pancreatic sections. The results proved that Mel-C/L nanoparticles showed remarkable anti-inflammatory, anti-coagulant, and anti-oxidant effects, in addition to its efficiency in reducing blood glucose levels of STZ-induced diabetic rats and great ability to promote the regeneration of pancreatic beta (β)-cells. Furthermore, Mel-C/L nanoparticles elevated the insulin level; and decreased the elevated levels of urea, creatinine and cholesterol. In conclusion, nanoparticles application decreased the administrated melatonin dose that in turn can diminish the side effects of free melatonin administration. |
format | Online Article Text |
id | pubmed-10313733 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-103137332023-07-02 Therapeutic effect of melatonin-loaded chitosan/lecithin nanoparticles on hyperglycemia and pancreatic beta cells regeneration in streptozotocin-induced diabetic rats Alaa, Habiba Abdelaziz, Mariam Mustafa, Maryam Mansour, Mustafa Magdy, Salma Mohsen, Salma El-Karamany, Yomna Farid, Alyaa Sci Rep Article Nanotechnology is used to overcome fundamental flaws in today's marketed pharmaceuticals that obstruct therapy, like restricted solubility and quick release of drugs into the bloodstream. In both human and animal researches, melatonin was demonstrated to regulate glucose levels. Despite the fact that melatonin is quickly transported through the mucosa, its sensitivity to be oxidized creates a difficulty in achieving the required dose. Additionally, due to its variable absorption and poor oral bioavailability necessitates the development of alternative delivery methods. The study aimed to synthesize melatonin loaded chitosan/lecithin (Mel-C/L) nanoparticles to be assessed in the treatment of streptozotocin (STZ)-induced diabetes in rats. The antioxidant, anti-inflammatory, and cytotoxicity properties of nanoparticles were estimated to determine the safety of manufactured nanoparticles for in vivo studies. In addition, Mel-C/L nanoparticles were administered to rats for eight weeks after inducing hyperglycemia. The therapeutic effect of Mel-C/L nanoparticles was assessed in all experimental groups by detecting insulin and blood glucose levels; observing improvements in liver and kidney functions as well as histological and immunohistochemical evaluation of rats’ pancreatic sections. The results proved that Mel-C/L nanoparticles showed remarkable anti-inflammatory, anti-coagulant, and anti-oxidant effects, in addition to its efficiency in reducing blood glucose levels of STZ-induced diabetic rats and great ability to promote the regeneration of pancreatic beta (β)-cells. Furthermore, Mel-C/L nanoparticles elevated the insulin level; and decreased the elevated levels of urea, creatinine and cholesterol. In conclusion, nanoparticles application decreased the administrated melatonin dose that in turn can diminish the side effects of free melatonin administration. Nature Publishing Group UK 2023-06-30 /pmc/articles/PMC10313733/ /pubmed/37391460 http://dx.doi.org/10.1038/s41598-023-36929-0 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Alaa, Habiba Abdelaziz, Mariam Mustafa, Maryam Mansour, Mustafa Magdy, Salma Mohsen, Salma El-Karamany, Yomna Farid, Alyaa Therapeutic effect of melatonin-loaded chitosan/lecithin nanoparticles on hyperglycemia and pancreatic beta cells regeneration in streptozotocin-induced diabetic rats |
title | Therapeutic effect of melatonin-loaded chitosan/lecithin nanoparticles on hyperglycemia and pancreatic beta cells regeneration in streptozotocin-induced diabetic rats |
title_full | Therapeutic effect of melatonin-loaded chitosan/lecithin nanoparticles on hyperglycemia and pancreatic beta cells regeneration in streptozotocin-induced diabetic rats |
title_fullStr | Therapeutic effect of melatonin-loaded chitosan/lecithin nanoparticles on hyperglycemia and pancreatic beta cells regeneration in streptozotocin-induced diabetic rats |
title_full_unstemmed | Therapeutic effect of melatonin-loaded chitosan/lecithin nanoparticles on hyperglycemia and pancreatic beta cells regeneration in streptozotocin-induced diabetic rats |
title_short | Therapeutic effect of melatonin-loaded chitosan/lecithin nanoparticles on hyperglycemia and pancreatic beta cells regeneration in streptozotocin-induced diabetic rats |
title_sort | therapeutic effect of melatonin-loaded chitosan/lecithin nanoparticles on hyperglycemia and pancreatic beta cells regeneration in streptozotocin-induced diabetic rats |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10313733/ https://www.ncbi.nlm.nih.gov/pubmed/37391460 http://dx.doi.org/10.1038/s41598-023-36929-0 |
work_keys_str_mv | AT alaahabiba therapeuticeffectofmelatoninloadedchitosanlecithinnanoparticlesonhyperglycemiaandpancreaticbetacellsregenerationinstreptozotocininduceddiabeticrats AT abdelazizmariam therapeuticeffectofmelatoninloadedchitosanlecithinnanoparticlesonhyperglycemiaandpancreaticbetacellsregenerationinstreptozotocininduceddiabeticrats AT mustafamaryam therapeuticeffectofmelatoninloadedchitosanlecithinnanoparticlesonhyperglycemiaandpancreaticbetacellsregenerationinstreptozotocininduceddiabeticrats AT mansourmustafa therapeuticeffectofmelatoninloadedchitosanlecithinnanoparticlesonhyperglycemiaandpancreaticbetacellsregenerationinstreptozotocininduceddiabeticrats AT magdysalma therapeuticeffectofmelatoninloadedchitosanlecithinnanoparticlesonhyperglycemiaandpancreaticbetacellsregenerationinstreptozotocininduceddiabeticrats AT mohsensalma therapeuticeffectofmelatoninloadedchitosanlecithinnanoparticlesonhyperglycemiaandpancreaticbetacellsregenerationinstreptozotocininduceddiabeticrats AT elkaramanyyomna therapeuticeffectofmelatoninloadedchitosanlecithinnanoparticlesonhyperglycemiaandpancreaticbetacellsregenerationinstreptozotocininduceddiabeticrats AT faridalyaa therapeuticeffectofmelatoninloadedchitosanlecithinnanoparticlesonhyperglycemiaandpancreaticbetacellsregenerationinstreptozotocininduceddiabeticrats |